信迪利单抗联合调强适形放疗和化疗用于晚期宫颈癌患者的效果

Download: PDF (515 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Received: 01 April 2026

PACS:

R737.33

Cite this article:

URL:

[1]	Kang Lihua, Zhai Fengyu, Liu Yuefen. The Efficacy of Sintilimab Combined with Platinum-based Chemotherapy in the Treatment of Advanced NSCLC Patients and Its Influence on Serum Notch1 and Dickkopf-1 Levels[J]. journal1, 2026, 46(1): 20-24.
[2]	Zhang Yueliang, Gan Huizhen, Lin Hui'e, Huang Honghong. The Effect of Sintilimab Combined with GP Regimen Chemotherapy on Serum VEGF,BFGF Levels and Immune Indicators in Advanced NSCLC Patients[J]. journal1, 2025, 45(6): 18-20.
[3]	Zhou Guohui. The Effect of Lenvatinib Combined with Xindilimab on Tumor Marker Levels and Survival in Patients with Advanced Liver Cancer[J]. journal1, 2025, 45(2): 4-7.
[4]	. [J]. journal1, 2024, 44(3): 96-98.
[5]	. [J]. journal1, 2023, 43(4): 105-107.